Renaissance Technologies’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $258K | Buy |
96,751
+77,500
| +403% | +$207K | ﹤0.01% | 3087 |
|
|
2025
Q1 | $155K | Buy |
19,251
+2,748
| +17% | +$22.1K | ﹤0.01% | 3124 |
|
|
2024
Q4 | $159K | Sell |
16,503
-17,273
| -51% | -$167K | ﹤0.01% | 3219 |
|
|
2024
Q3 | $628K | Sell |
33,776
-624
| -2% | -$11.6K | ﹤0.01% | 2682 |
|
|
2024
Q2 | $572K | Sell |
34,400
-3,056
| -8% | -$50.8K | ﹤0.01% | 2631 |
|
|
2024
Q1 | $650K | Buy |
37,456
+4,327
| +13% | +$75.1K | ﹤0.01% | 2752 |
|
|
2023
Q4 | $518K | Buy |
33,129
+18,619
| +128% | +$291K | ﹤0.01% | 2751 |
|
|
2023
Q3 | $718K | Buy |
14,510
+1,158
| +9% | +$57.3K | ﹤0.01% | 2520 |
|
|
2023
Q2 | $1.04M | Sell |
13,352
-6,118
| -31% | -$478K | ﹤0.01% | 2444 |
|
|
2023
Q1 | $1.76M | Buy |
19,470
+1,479
| +8% | +$134K | ﹤0.01% | 2101 |
|
|
2022
Q4 | $2.12M | Buy |
17,991
+5,356
| +42% | +$632K | ﹤0.01% | 2029 |
|
|
2022
Q3 | $2.29M | Sell |
12,635
-482
| -4% | -$87.5K | ﹤0.01% | 1928 |
|
|
2022
Q2 | $1.18M | Buy |
13,117
+10,808
| +468% | +$970K | ﹤0.01% | 2602 |
|
|
2022
Q1 | $358K | Buy |
+2,309
| New | +$358K | ﹤0.01% | 3387 |
|
|
2021
Q3 | – | Sell |
-1,217
| Closed | -$553K | – | 3922 |
|
|
2021
Q2 | $553K | Buy |
+1,217
| New | +$553K | ﹤0.01% | 2924 |
|